IO Biotech CEO Mai-Britt Zocca's 2023 pay jumps 124% to $1.6M
IO Biotech reports 2023 executive compensation
By ExecPay News
Published: April 24, 2024
IO Biotech reported fiscal year 2023 executive compensation information on April 24, 2024.
In 2023, four IO Biotech executives received on average a compensation package of $1.1M, a 73% increase compared to previous year.
Average pay of disclosed executives at IO Biotech
Mai-Britt Zocca, Chief Executive Officer, received $1.6M in total, which increased by 124% compared to 2022. 46% of Zocca's compensation, or $753K, was in option awards. Zocca also received $297K in non-equity incentive plan, $541K in salary, as well as $54K in other compensation.
Eva Ehrnrooth, Chief Medical Officer, received a compensation package of $968K, which increased by 71% compared to previous year. 47% of the compensation package, or $454K, was in salary.
Qasim Ahmad, Chief Medical Officer, earned $921K in 2023.
Devin W. Smith, General Counsel, received $917K in 2023.
Related executives
You may also like
Source: SEC filing on April 24, 2024.